These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 25646808

  • 21. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1.
    Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Pan Z, Kang T, Huang W.
    Carcinogenesis; 2011 Jul; 32(7):1033-42. PubMed ID: 21565830
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.
    Oncogene; 2012 Jul 12; 31(28):3357-69. PubMed ID: 22056881
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.
    Koo KH, Kwon H.
    Cell Death Dis; 2018 Jan 23; 9(2):77. PubMed ID: 29362401
    [Abstract] [Full Text] [Related]

  • 24. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3.
    Zhao G, Zhang JG, Shi Y, Qin Q, Liu Y, Wang B, Tian K, Deng SC, Li X, Zhu S, Gong Q, Niu Y, Wang CY.
    PLoS One; 2013 Jan 23; 8(9):e73803. PubMed ID: 24040078
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer.
    Yi JM, Kang EJ, Kwon HM, Bae JH, Kang K, Ahuja N, Yang K.
    Oncotarget; 2017 Apr 18; 8(16):26600-26612. PubMed ID: 28460450
    [Abstract] [Full Text] [Related]

  • 27. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
    Anandanadesan R, Gong Q, Chipitsyna G, Witkiewicz A, Yeo CJ, Arafat HA.
    J Gastrointest Surg; 2008 Jan 18; 12(1):57-66. PubMed ID: 18026817
    [Abstract] [Full Text] [Related]

  • 28. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
    He XP, Shao Y, Li XL, Xu W, Chen GS, Sun HH, Xu HC, Xu X, Tang D, Zheng XF, Xue YP, Huang GC, Sun WH.
    FEBS J; 2012 Nov 18; 279(22):4201-12. PubMed ID: 23013439
    [Abstract] [Full Text] [Related]

  • 29. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
    Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C.
    Carcinogenesis; 2011 Aug 18; 32(8):1183-9. PubMed ID: 21665894
    [Abstract] [Full Text] [Related]

  • 30. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.
    Gao S, Wang P, Hua Y, Xi H, Meng Z, Liu T, Chen Z, Liu L.
    Oncotarget; 2016 Jan 12; 7(2):1608-18. PubMed ID: 26636540
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
    Chen X, He D, Dong XD, Dong F, Wang J, Wang L, Tang J, Hu DN, Yan D, Tu L.
    Invest Ophthalmol Vis Sci; 2013 Mar 01; 54(3):2248-56. PubMed ID: 23404119
    [Abstract] [Full Text] [Related]

  • 32. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.
    Vorvis C, Hatziapostolou M, Mahurkar-Joshi S, Koutsioumpa M, Williams J, Donahue TR, Poultsides GA, Eibl G, Iliopoulos D.
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun 01; 310(11):G1124-37. PubMed ID: 27151939
    [Abstract] [Full Text] [Related]

  • 33. Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer.
    Batchu RB, Gruzdyn OV, Qazi AM, Kaur J, Mahmud EM, Weaver DW, Gruber SA.
    Surgery; 2015 Oct 01; 158(4):981-6; discussion 986-7. PubMed ID: 26189069
    [Abstract] [Full Text] [Related]

  • 34. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, Wang FH, Chiao LJ, Pelicano H, Huang P, Li YH, Xu RH.
    Hepatology; 2014 Aug 01; 60(2):598-609. PubMed ID: 24616020
    [Abstract] [Full Text] [Related]

  • 35. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.
    Long M, Zhan M, Xu S, Yang R, Chen W, Zhang S, Shi Y, He Q, Mohan M, Liu Q, Wang J.
    Mol Cancer; 2017 Oct 27; 16(1):167. PubMed ID: 29078789
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.
    Li H, Bian C, Liao L, Li J, Zhao RC.
    Breast Cancer Res Treat; 2011 Apr 27; 126(3):565-75. PubMed ID: 20505989
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL.
    FEBS J; 2015 Feb 27; 282(3):579-94. PubMed ID: 25475121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.